Specifically, the IGF-2 gene in cancer patients with lymph node metastasis had a methylation frequency of 46.3%, which was significantly lower than that in patients without lymph node metastasis (17.2%, P < 0.05, Table 2). This evidence concerns the gene IGF2 and cancer.